Arvida Group Limited, together with its subsidiaries, owns, develops, and operates retirement villages and rest homes for the elderly in New Zealand.
Undervalued second-rate dividend payer.
Share Price & News
How has Arvida Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ARV has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: ARV exceeded the NZ Healthcare industry which returned 37.1% over the past year.
Return vs Market: ARV exceeded the NZ Market which returned 22.4% over the past year.
Price Volatility Vs. Market
How volatile is Arvida Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall StArvida Group Limited (NZSE:ARV) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
4 days ago | Simply Wall StHow Many Arvida Group Limited (NZSE:ARV) Shares Did Insiders Buy, In The Last Year?
2 weeks ago | Simply Wall StHas Arvida Group Limited (NZSE:ARV) Been Employing Capital Shrewdly?
Is Arvida Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ARV (NZ$1.86) is trading below our estimate of fair value (NZ$2.88)
Significantly Below Fair Value: ARV is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ARV is good value based on its PE Ratio (11.2x) compared to the Healthcare industry average (24.4x).
PE vs Market: ARV is good value based on its PE Ratio (11.2x) compared to the NZ market (20.7x).
Price to Earnings Growth Ratio
PEG Ratio: ARV is poor value based on its PEG Ratio (2.8x)
Price to Book Ratio
PB vs Industry: ARV is good value based on its PB Ratio (1.2x) compared to the NZ Healthcare industry average (1.2x).
How is Arvida Group forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ARV's forecast earnings growth (4% per year) is above the savings rate (1.3%).
Earnings vs Market: ARV's earnings (4% per year) are forecast to grow slower than the NZ market (7.9% per year).
High Growth Earnings: ARV's earnings are forecast to grow, but not significantly.
Revenue vs Market: ARV's revenue (8.9% per year) is forecast to grow faster than the NZ market (5.5% per year).
High Growth Revenue: ARV's revenue (8.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ARV's Return on Equity is forecast to be low in 3 years time (9.5%).
How has Arvida Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ARV has a large one-off gain of NZ$60.1M impacting its September 30 2019 financial results.
Growing Profit Margin: ARV's current net profit margins (47.1%) are lower than last year (49.8%).
Past Earnings Growth Analysis
Earnings Trend: ARV's earnings have grown significantly by 34.9% per year over the past 5 years.
Accelerating Growth: ARV's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ARV had negative earnings growth (-0.2%) over the past year, making it difficult to compare to the Healthcare industry average (-2.9%).
Return on Equity
High ROE: ARV's Return on Equity (10.1%) is considered low.
Return on Assets
Return on Capital Employed
How is Arvida Group's financial position?
Financial Position Analysis
Short Term Liabilities: ARV's short term assets (NZ$39.3M) do not cover its short term liabilities (NZ$45.7M).
Long Term Liabilities: ARV's short term assets (NZ$39.3M) do not cover its long term liabilities (NZ$1.1B).
Debt to Equity History and Analysis
Debt Level: ARV's debt to equity ratio (38.1%) is considered satisfactory.
Reducing Debt: ARV's debt to equity ratio has increased from 3.5% to 38.1% over the past 5 years.
Debt Coverage: ARV's debt is well covered by operating cash flow (26.4%).
Interest Coverage: ARV's interest payments on its debt are not well covered by EBIT (2.9x coverage).
Inventory Level: ARV has a low level of unsold assets or inventory.
Debt Coverage by Assets: ARV's debt is not covered by short term assets (assets are 0.1x debt).
What is Arvida Group's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: ARV's dividend (2.88%) is higher than the bottom 25% of dividend payers in the NZ market (2.85%).
High Dividend: ARV's dividend (2.88%) is low compared to the top 25% of dividend payers in the NZ market (5.38%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, ARV has been paying a dividend for less than 10 years.
Growing Dividend: ARV's dividend payments have increased, but the company has only paid a dividend for 5 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (33.9%), ARV's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ARV's dividends in 3 years are forecast to be covered by earnings (54.9% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Bill McDonald 0
Mr. William Adam McDonald, also known as Bill, B.Bus, MAgribus serves as the Chief Executive Officer of Arvida Group Limited. Mr. McDonald joined Arvida as a consultant in September 2014. He is an experien ...
|Independent Chairman||5.3yrs||NZ$150.00k||0.10% NZ$1.0m|
|Independent Director||5.3yrs||NZ$94.00k||0.069% NZ$701.2k|
|Independent Director||4.8yrs||NZ$82.00k||0.035% NZ$353.5k|
|Independent Director||4.8yrs||NZ$90.00k||0.024% NZ$248.0k|
|Independent Director||6.1yrs||NZ$82.00k||0.34% NZ$3.5m|
Experienced Board: ARV's board of directors are considered experienced (5.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.3%.
Arvida Group Limited's company bio, employee growth, exchange listings and data sources
- Name: Arvida Group Limited
- Ticker: ARV
- Exchange: NZSE
- Founded: 2014
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: NZ$1.013b
- Shares outstanding: 541.89m
- Website: https://www.arvida.co.nz
Number of Employees
- Arvida Group Limited
- 39 Market Place
- Level 1
- New Zealand
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ARV||NZSE (New Zealand Stock Exchange)||Yes||Ordinary Shares||NZ||NZD||Dec 2014|
Arvida Group Limited, together with its subsidiaries, owns, develops, and operates retirement villages and rest homes for the elderly in New Zealand. It operates approximately 29 retirement villages with 1,722 aged care beds and 1,955 retirement units. The company was formerly known as Hercules Limited. Arvida Group Limited was founded in 2014 and is based in Auckland, New Zealand.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/24 10:54|
|End of Day Share Price||2020/02/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.